Reportlinker Adds The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand
NEW YORK, Jan. 27 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand
Summary
GBI Research's new report, "The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand" provides key data, information and analysis on the global in-vitro diagnostics market, a key segment within the medical equipment industry. This medical device report provides market landscape, competitive landscape and market trends information on seven in-vitro diagnostics market categories - Clinical Chemistry, Genetic Testing, Histology and Cytology, Immuno Chemistry, Infectious Immunology, Microbiology Culture and Haematology. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.
Scope
- Key geographies including the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Belgium, Netherlands, Japan, China, India, Australia, Taiwan, republic of Korea, Brazil, Argentina, Mexico, Israel and South Africa.
- Global Market size and company share data for seven In-Vitro Diagnostics market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture and haematology.
- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008.
- Qualitative analysis of key market trends, market drivers and restraints by categories and segments.
- Competitive landscape and key company profiles. Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, Becton, Dickinson (BD), Bio-Rad Laboratories, Inverness Medical Innovations, Sysmex, Gen-Probe and Dade Behring.
- Key in-pipeline products and technologies expected to hit the global In-Vitro Diagnostics market in the near future.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the In-Vitro Diagnostics market globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline. Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What's the next big thing in the In-Vitro Diagnostics market landscape? – Identify, understand and capitalize
- Make more informed business decisions from the insightful and in-depth analysis of the In-Vitro Diagnostics market and the factors shaping it.
1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 7
1.2 List of Figures Introduction and Overview 11
2.1 In-Vitro Diagnostics Overview 11
3 Global IVD Market: Market Characterization 12
3.1 Global IVD Market, Revenues ($m), 2002 – 2009 12
3.2 Global IVD Market, Revenue Forecasts ($m), 2009 – 2016 13
3.3 Global IVD Market, Key Company Shares (%), 2008 14
3.4 Global In-vitro Devices, Key Market Trends 15
3.4.1 Entry of In Diagnostic Imaging Players Into In Vitro Diagnostics Market Has Set Stage for New Technologies to Be Developed By Marrying the Two Disciplines 15
3.4.2 Large Number of Private Equity/ Venture Capital (PE/VC) Investments and Collaborations in the IVD Sector to Fuel Innovation 16
3.4.3 Consolidation of Laboratories across the World 16
3.5 Global In Vitro Diagnostics: Key Technology Trends 17
3.5.1 Emerging technologies for cutting lab costs 17
3.5.2 New Technologies Improve Speed and Accuracy 18
3.6 Global In-vitro Devices, Market Drivers 20
3.6.1 Economic Market Drivers 20
3.6.2 Technology Market Drivers 22
3.6.3 Regulatory Market Drivers 22
3.6.4 Social Market Drivers 22
3.7 In-vitro Devices, Market Restraints 23
3.7.1 Economic Market Restraints 23
3.7.2 Social Market Restraints 24
4 Global IVD Market: Market Category Analysis and Forecasts 25
4.1 Clinical Chemistry Market: Market Characterization 25
4.1.1 Global Clinical Chemistry Market, Revenues ($m), 2002–2009 25
4.1.2 Global Clinical Chemistry Market, Revenue Forecasts ($m), 2009–2016 26
4.1.3 Global Clinical Chemistry Market, Key Company Shares (%), 2008 27
4.1.4 Clinical Chemistry Market: Market Drivers 28
4.1.5 Clinical Chemistry Market: Market Restraints 29
4.2 Immuno Chemistry Market: Market Characterization 30
4.2.1 Global Immuno Chemistry Market, Revenues ($m), 2002 – 2009 30
4.2.2 Global Immuno Chemistry Market, Revenue Forecasts ($m), 2009 – 2016 31
4.2.3 Global Immuno Chemistry Market, Key Company Shares (%), 2008 32
4.2.4 Immuno Chemistry Market: Market Drivers 33
4.2.5 Immuno Chemistry Market: Market Restraints 35
4.3 Haematology Market: Market Characterization 36
4.3.1 Global Haematology Market, Revenues ($m), 2002 – 2009 36
4.3.2 Global Haematology Market, Revenue Forecasts ($m), 2009 – 2016 37
4.3.3 Global Haematology Market, Key Company Shares (%), 2008 38
4.3.4 Haematology Market: Market Drivers 39
4.3.5 Haematology Market: Market Restraints 40
4.4 Histology and Cytology Market: Market Characterization 41
4.4.1 Global Histology and Cytology Market, Revenue ($m), 2002 – 2009 41
4.4.2 Global Histology and Cytology Market, Revenue Forecasts ($m), 2009 – 2016 42
4.4.3 Global Histology and Cytology Market, Key Company Shares (%), 2008 43
4.4.4 Histology and Cytology Market: Market Drivers 44
4.4.5 Histology and Cytology Market: Market Restraints 45
4.5 Microbiology Culture Market: Market Characterization 46
4.5.1 Global Microbiology Culture Market, Revenues ($m), 2002 – 2009 46
4.5.2 Global Microbiology Culture Market, Revenue Forecasts ($m), 2009 – 2016 47
4.5.3 Global Microbiology Culture Market, Key Company Shares (%), 2008 48
4.5.4 Global Microbiology Culture Market: Market Drivers 49
4.5.5 Global Market Restraints Microbiology Culture Market: Market Restraints 50
4.6 Infectious Immunology Market: Market Characterization 51
4.6.1 Global Infectious Immunology Market, Revenues ($m), 2002 – 2009 51
4.6.2 Global Infectious Immunology Market, Revenue Forecasts ($m), 2009 – 2016 52
4.6.3 Global Infectious Immunology Market, Key Company Shares (%), 2008 53
4.6.4 Global Infectious Immunology Market: Market Drivers 53
4.6.5 Global Infectious Immunology Market: Market Restraints 54
4.7 Genetic Testing Market: Market Characterization 55
4.7.1 Global Genetic Testing Market, Revenues ($m), 2002 – 2009 55
4.7.2 Global Genetic Testing Market, Key Company Shares (%), 2008 57
4.7.3 Global Genetic Testing Market: Market Drivers 58
4.7.4 Global Genetic Testing Market: Market Restraints 59
5 Global IVD Market: Country Analysis and Forecasts 61
5.1 Global IVD Market: Geographic Trends Analysis 61
5.2 Market Characterization, North America, 2002 – 2016 62
5.2.1 The US IVD Market, Revenues ($m), 2002 – 2009 62
5.2.2 The US IVD Market, Revenues ($m), 2009 – 2016 63
5.2.3 Canada IVD Market, Revenues ($m), 2002 – 2009 64
5.2.4 North America IVD Market, Market Drivers 66
5.2.5 North America IVD Market, Market Restraints 66
5.3 Market Characterization, Europe, 2002 – 2016 67
5.3.1 The UK IVD Market, Revenues ($m), 2002 – 2009 67
5.3.2 The UK IVD Market, Revenues ($m), 2009 – 2016 68
5.3.3 Germany IVD Market, Revenues ($m), 2002 – 2009 69
5.3.4 Germany IVD Market, Revenues ($m), 2009 – 2016 70
5.3.5 France IVD Market, Revenues ($m), 2002 – 2009 71
5.3.6 France IVD Market, Revenues ($m), 2009 – 2016 73
5.3.7 Italy IVD Market, Revenues ($m), 2002 – 2009 74
5.3.8 Italy IVD Market, Revenues ($m), 2009 – 2016 75
5.3.9 Spain IVD Market, Revenues ($m), 2002 – 2009 76
5.3.10 Spain IVD Market, Revenues ($m), 2009 – 2016 77
5.3.11 Belgium IVD Market, Revenues ($m), 2002 – 2009 78
5.3.12 Belgium IVD Market, Revenues ($m), 2009 – 2016 79
5.3.13 The Netherlands IVD Market, Revenues ($m), 2002 – 2009 80
5.3.14 The Netherlands IVD Market, Revenues ($m), 2009 – 2016 81
5.3.15 Europe IVD Market, Market Drivers 81
5.3.16 Europe IVD Market, Market Restraints 82
5.4 Market Characterization, Asia Pacific, 2002 – 2016 83
5.4.1 Japan IVD Market, Revenues ($m), 2002 – 2009 83
5.4.2 Japan IVD Market, Revenues ($m), 2009 – 2016 84
5.4.3 China IVD Market, Revenues ($m), 2002 – 2009 85
5.4.4 China IVD Market, Revenues ($m), 2009 – 2016 86
5.4.5 India IVD Market, Revenues ($m), 2002 – 2009 87
5.4.6 India IVD Market, Revenues ($m), 2009 – 2016 88
5.4.7 Australia IVD Market, Revenues ($m), 2002 – 2009 90
5.4.8 Australia IVD Market, Revenues ($m), 2009 – 2016 91
5.4.9 Taiwan IVD Market, Revenues ($m), 2002 – 2009 92
5.4.10 Taiwan IVD Market, Revenues ($m), 2009 – 2016 93
5.4.11 Republic of Korea IVD Market, Revenues ($m), 2002 – 2009 94
5.4.12 Republic of Korea IVD Market, Revenues ($m), 2009 – 2016 95
5.4.13 Asia Pacific IVD Market, Market Drivers 96
5.4.14 Asia Pacific IVD Market, Market Restraints 96
5.5 Market Characterization, South and Central America, 2002 – 2016 97
5.5.1 Brazil IVD Market, Revenues ($m), 2002 – 2009 97
5.5.2 Brazil IVD Market, Revenues ($m), 2009 – 2016 98
5.5.3 Argentina IVD Market, Revenues ($m), 2002 – 2009 99
5.5.4 Argentina IVD Market, Revenues ($m), 2009 – 2016 100
5.5.5 Mexico IVD Market, Revenues ($m), 2002 – 2009 101
5.5.6 Mexico IVD Market, Revenues ($m), 2009 – 2016 102
5.5.7 South and Central America IVD Market, Market Drivers 103
5.5.8 South and Central America IVD Market, Market Restraints 103
5.6 Market Characterization, Middle East and Africa, 2002 – 2016 104
5.6.1 Israel IVD Market, Revenues ($m), 2002 – 2009 104
5.6.2 Israel IVD Market, Revenues ($m), 2009 – 2016 105
5.6.3 South Africa IVD Market, Revenues ($m), 2002 – 2009 106
5.6.4 South Africa IVD Market, Revenues ($m), 2009 – 2016 107
5.6.5 Middle East and Africa IVD Market, Market Drivers 108
5.6.6 Middle East and Africa IVD Market, Market Restraints 108
6 Global IVD Market: Strategic Competitive Assessment 109
6.1 Key Market Participants 109
6.1.1 F. Hoffmann-La Roche Ltd 109
6.1.2 Siemens Medical Solutions USA, Inc. 111
6.1.3 Abbott Laboratories 113
6.1.4 Beckman Coulter, Inc. 115
6.1.5 bioMerieux Sa 117
6.1.6 Ortho-Clinical Diagnostics 118
6.1.7 Becton, Dickinson and Company 119
6.1.8 Bio-Rad Laboratories, Inc. 120
6.1.9 Inverness Medical Innovations, Inc 121
7 Global IVD Market: Product Pipeline Analysis 124
7.1 Pipeline Products Analysis by Category 124
7.1.1 Pipeline Products Analysis: Immuno Chemistry Market 125
7.1.2 Pipeline Products Analysis: Infectious Immunology 126
7.2 Key Pipeline Products Currently Undergoing Development 126
7.2.1 Clinical Chemistry Pipeline Products 126
7.2.2 Genetic Testing 126
7.2.3 Haematology 127
7.2.4 Immunochemistry 128
7.2.5 Infectious Immunology 129
7.2.6 Microbiology Culture 130
7.2.7 Histology and Cytology 130
8 Global IVD Market: Consolidation Landscape 131
8.1 Deals by Type, 2006 – 2009 131
8.2 Deals by Value and Volume, 2006 – 2009 132
8.3 List of Deals in 2009 132
8.4 Top 10 Acquisitions By Value, 2009 135
8.4.1 Agilent Technologies Receives Shareholders Approval To Acquire Varian 135
8.4.2 Beckman Coulter Completes Acquisition Of Olympus-DS From OLYMPUS 135
8.4.3 MDS Receives Shareholder Approval To Sell MDS Analytical Technologies To Danaher 135
8.4.4 Thermo Fisher Scientific Completes Acquisition Of B.R.A.H.M.S. 136
8.4.5 Corning Acquires Axygen BioScience And Its Subsidiaries From American Capital 136
8.4.6 Becton, Dickinson and Company Completes Acquisition Of HandyLab 136
8.4.7 Inverness Medical Innovations Completes Acquisition Of Concateno From Marwyn 137
8.4.8 Laboratory Corporation of America Holdings Completes Acquisition Of Monogram Biosciences 137
8.4.9 Gen-Probe Acquires Tepnel Life Sciences 137
9 Appendix 139
9.1 Definitions 139
9.1.1 Clinical Chemistry 139
9.1.2 Immunochemistry Test Reagents 140
9.1.3 Haematology 141
9.1.4 Histology And Cytology 142
9.1.5 Microbiology Culture 143
9.1.6 Infectious Immunology 143
9.1.7 Genetic Testing 144
9.2 Acronyms 144
9.3 Methodology 144
9.3.1 Secondary Research 145
9.3.2 Primary Research 145
9.3.3 Models 146
9.3.4 Forecasts 146
9.3.5 Expert Panels 146
9.4 Contact Us 146
9.5 Disclaimer 147
1.1 List of Tables
Table 1: IVD Market, Global, Revenue ($m), 2002-2009 12
Table 2: IVD Market, Global, Revenue ($m), 2009-2016 13
Table 3: IVD Market, Global, Company Share ($m), 2008 14
Table 4: Clinical Chemistry Market, Global, Revenues ($m), 2002–2009 25
Table 5: Clinical Chemistry Market, Global, Revenue ($m), 2009–2016 26
Table 6: Clinical Chemistry Market, Global, Company Share ($m), 2008 27
Table 7: Clinical Chemistry Market, Comparison of Top 10 Countries By Revenue, 2002–2016 28
Table 8: Immuno Chemistry Market, Global, Revenues ($m), 2002–2009 30
Table 9: Immuno Chemistry Market, Global, Revenue ($m), 2009–2016 32
Table 10: Immuno Chemistry Market, Global, Company Share ($m),2008 33
Table 11: Immuno Chemistry Market, Comparison of Top 10 Countries By Revenue, 2002–2016 34
Table 12: Haematology Market, Global, Revenues ($m), 2002–2009 36
Table 13: Haematology Market, Global, Revenue ($m), 2009–2016 37
Table 14: Haematology Market, Global, Company Share ($m),2008 38
Table 15: Haematology Market, Comparison of Top 10 Countries By Revenue, 2002–2016 39
Table 16: Histology and Cytology Market, Global, Revenue ($m), 2002–2009 41
Table 17: Histology and Cytology Market, Global, Revenue ($m), 2009–2016 42
Table 18: Histology and Cytology Market, Global, Company Share ($m),2008 43
Table 19: Histology and Cytology Market, Comparison of Top 10 Countries By Revenue,
2002–2016 44
Table 20: Microbiology Culture Market, Global, Revenue ($m), 2002–2009 46
Table 21: Microbiology Culture Market, Global, Revenue ($m), 2009–2016 47
Table 22: Microbiology Culture Market, Global, Company Share ($m),2008 48
Table 23: Microbiology Culture Market, Comparison of Top 10 Countries By Revenue,
2002–2016 49
Table 24: Infectious Immunology Market, Global, Revenue ($m), 2002–2009 51
Table 25: Infectious Immunology Market, Global, Revenue ($m), 2009–2016 52
Table 26: Infectious Immunology Market, Global, Company Share ($m),2008 53
Table 27: Genetic Testing Market, Global, Revenue ($m), 2002–2009 55
Table 28: Genetic Testing Market, Global, Revenue ($m), 2009–2016 56
Table 29: Global Genetic Testing Market, Global, Company Share ($m),2008 57
Table 30: Genetic Testing Market, Comparison of Top 10 Countries By Revenue, 2002–2016 58
Table 31: IVD Market, US, Revenue ($m), 2002-2009 62
Table 32: IVD Market, US, Revenue ($m), 2009-2016 63
Table 33: IVD Market, Canada, Revenue ($m), 2002-2009 64
Table 34: IVD Market, Canada, Revenue ($m), 2009-2016 65
Table 35: IVD Market, The UK, Revenue ($m), 2002-2009 67
Table 36: IVD Market, The UK, Revenue ($m), 2009-2016 68
Table 37: IVD Market, Germany, Revenue ($m), 2002-2009 69
Table 38: IVD Market, Germany, Revenue ($m), 2009-2016 70
Table 39: IVD Market, France, Revenue ($m), 2002-2009 72
Table 40: IVD Market, France, Revenue ($m), 2009-2016 73
Table 41: IVD Market, Italy, Revenue ($m), 2002-2009 74
Table 42: IVD Market, Italy, Revenue ($m), 2009-2016 75
Table 43: IVD Market, Spain, Revenue ($m), 2002-2009 76
Table 44: IVD Market, Spain, Revenue ($m), 2009-2016 77
Table 45: IVD Market, Belgium, Revenue ($m), 2002-2009 78
Table 46: IVD Market, Belgium, Revenue ($m), 2009-2016 79
Table 47: IVD Market, The Netherlands, Revenue ($m), 2002-2009 80
Table 48: IVD Market, The Netherlands, Revenue ($m), 2009-2016 81
Table 49: IVD Market, Japan, Revenue ($m), 2002-2009 83
Table 50: IVD Market, Japan, Revenue ($m), 2009-2016 84
Table 51: IVD Market, China, Revenue ($m), 2002-2009 85
Table 52: IVD Market, China, Revenue ($m), 2009-2016 86
Table 53: IVD Market, India, Revenue ($m), 2002-2009 88
Table 54: IVD Market, India, Revenue ($m), 2002-2009 89
Table 55: IVD Market, Australia, Revenue ($m), 2002-2009 90
Table 56: IVD Market, Australia, Revenue ($m), 2009-2016 91
Table 57: IVD Market, Taiwan, Revenue ($m), 2002-2009 92
Table 58: IVD Market, Taiwan, Revenue ($m), 2009-2016 93
Table 59: IVD Market, Republic of Korea, Revenue ($m), 2002-2009 94
Table 60: IVD Market, Republic of Korea, Revenue ($m), 2009-2016 95
Table 61: IVD Market, Brazil, Revenue ($m), 2002-2009 97
Table 62: IVD Market, Brazil, Revenue ($m), 2009-2016 98
Table 63: IVD Market, Argentina, Revenue ($m), 2002-2009 99
Table 64: IVD Market, Argentina, Revenue ($m), 2009-2016 100
Table 65: IVD Market, Mexico, Revenue ($m), 2002-2009 101
Table 66: IVD Market, Mexico, Revenue ($m), 2009-2016 102
Table 67: IVD Market, Israel, Revenue ($m), 2002-2009 104
Table 68: IVD Market, Israel, Revenue ($m), 2009-2016 105
Table 69: IVD Market, South Africa, Revenue ($m), 2002-2009 106
Table 70: IVD Market, South Africa, Revenue ($m), 2009-2016 107
Table 71: Roche's Merger and Acquisitions, IVD Market, 2007–2009 109
Table 72: Roche IVD Pipeline Product Portfolio 110
Table 73: Siemens Medical Solutions IVD Pipeline Product Portfolio 112
Table 74: Siemen's Merger and Acquisitions, IVD Market, 2007–2009 113
Table 75: Abbott Laboratories' Mergers and Acquisitions, IVD Market, 2007–2009 114
Table 76: Abbott Laboratories IVD Pipeline Products 114
Table 77: Beckman Coulter's Mergers and Acquisitions, IVD Market, 2007–2009 116
Table 78: Beckman Coulter, Inc. IVD Pipeline Products 117
Table 79: bioMerieux's Mergers and Acquisitions, IVD Market, 2007–2009 118
Table 80: bioMerieux Sa IVD Pipeline Products 118
Table 81: Ortho-Clinical Diagnostics, IVD Pipeline Products 119
Table 82: Becton Dickinson, Mergers and Acquisitions, IVD Market, 2007–2009 120
Table 83: Becton, Dickinson Inc. IVD Pipeline Portfolio 120
Table 84: Bio-Rad, Merger and Acquisitions, IVD Market, 2007–2009 121
Table 85: Inverness Medical Innovations, Inc., Mergers and Acquisitions, IVD Market, 2007–2009 122
Table 86: Inverness Medical Innovations IVD Pipeline Portfolio 123
Table 87: IVD Market, Global, Pipeline Products by Category, 2009 124
Table 88: Immuno Chemistry Market, Global, Pipeline Products Analysis, 2009 125
Table 89: Infectious Immunology Market, Global, 2009 126
Table 90: Deals By Type, Global IVD Market, 2006-2009 131
Table 91: Key Deals, Global IVD Market, 2009 132
1.2 List of Figures
Figure 1: IVD Market, Global, Revenue ($m), 2002-2009 12
Figure 2: IVD Market, Global, Revenue ($m), 2009-2016 13
Figure 3: IVD Market, Global, Company Share (%),2008 14
Figure 4: Global In-vitro Devices: Key Market Trends 15
Figure 5: Global Laboratory Consolidation Landscape, 2005–2009 16
Figure 6: Global In Vitro Diagnostics: Key Technology Trends 17
Figure 7: Global In Vitro Diagnostics: Market Drivers and Restraints 19
Figure 8: List of Retail Clinics in the US and Diagnostic IVD Tests Offered 21
Figure 9: Clinical Chemistry Market, Global, Revenues ($m), 2002–2009 25
Figure 10: Clinical Chemistry Market, Global, Revenue ($m), 2009–2016 26
Figure 11: Clinical Chemistry Market, Global, Company Share (%),2008 27
Figure 12: Clinical Chemistry Market, Comparison of Top 10 Countries By Revenue, 2002–2016 28
Figure 13: Immuno Chemistry Market, Global, Revenues ($m), 2002–2009 30
Figure 14: Immuno Chemistry Market, Global, Revenue ($m), 2009–2016 31
Figure 15: Immuno Chemistry Market, Global, Company Share (%),2008 32
Figure 16: Immuno Chemistry Market, Comparison of Top 10 Countries By Revenue, 2002–2016 33
Figure 17: Haematology Market, Global, Revenues ($m), 2002–2009 36
Figure 18: Haematology Market, Global, Revenue ($m), 2009–2016 37
Figure 19: Haematology Market, Global, Company Share (%),2008 38
Figure 20: Haematology Market, Comparison of Top 11 Countries By Revenue, 2002–2016 39
Figure 21: Histology and Cytology Market, Global, Revenue ($m), 2002–2009 41
Figure 22: Histology and Cytology Market, Global, Revenue ($m), 2009–2016 42
Figure 23: Histology and Cytology Market, Global, Company Share (%),2008 43
Figure 24: Histology and Cytology Market, Comparison of Top 10 Countries By Revenue,
2002–2016 44
Figure 25: Microbiology Culture Market, Global, Revenue ($m), 2002–2009 46
Figure 26: Microbiology Culture Market, Global, Revenue ($m), 2009–2016 47
Figure 27: Microbiology Market, Global, Company Share (%),2008 48
Figure 28: Microbiology Culture Market, Comparison of Top 10 Countries By Revenue,
2002–2016 49
Figure 29: Infectious Immunology Market, Global, Revenue ($m), 2002–2009 51
Figure 30: Infectious Immunology Market, Global, Revenue ($m), 2009–2016 52
Figure 31: Infectious Immunology Market, Global, Company Share (%),2008 53
Figure 32: Genetic Testing Market, Global, Revenue ($m), 2002–2009 55
Figure 33: Genetic Testing Market, Global, Revenue ($m), 2009–2016 56
Figure 34: Global Genetic Testing Market, Global, Company Share (%),2008 57
Figure 35: Genetic Testing Market, Comparison of Top 10 Countries By Revenue, 2002–2016 58
Figure 36: IVD Market, Global, Geographic Trends Analysis 61
Figure 37: IVD Market, US, Revenue ($m), 2002-2009 62
Figure 38: IVD Market, US, Revenue ($m), 2009-2016 63
Figure 39: IVD Market, Canada, Revenue ($m), 2002-2009 64
Figure 40: IVD Market, Canada, Revenue ($m), 2009-2016 65
Figure 41: IVD Market, The UK, Revenue ($m), 2002-2009 67
Figure 42: IVD Market, The UK, Revenue ($m), 2009-2016 68
Figure 43: IVD Market, Germany, Revenue ($m), 2002-2009 69
Figure 44: IVD Market, Germany, Revenue ($m), 2009-2016 70
Figure 45: IVD Market, France, Revenue ($m), 2002-2009 71
Figure 46: IVD Market, France, Revenue ($m), 2009-2016 73
Figure 47: IVD Market, Italy, Revenue ($m), 2002-2009 74
Figure 48: IVD Market, Italy, Revenue ($m), 2009-2016 75
Figure 49: IVD Market, Spain, Revenue ($m), 2002-2009 76
Figure 50: IVD Market, Spain, Revenue ($m), 2009-2016 77
Figure 51: IVD Market, Belgium, Revenue ($m), 2002-2009 78
Figure 52: IVD Market, Belgium, Revenue ($m), 2009-2016 79
Figure 53: IVD Market, The Netherlands, Revenue ($m), 2002-2009 80
Figure 54: IVD Market, The Netherlands, Revenue ($m), 2009-2016 81
Figure 55: IVD Market, Japan, Revenue ($m), 2002-2009 83
Figure 56: IVD Market, Japan, Revenue ($m), 2009-2016 84
Figure 57: IVD Market, China, Revenue ($m), 2002-2009 85
Figure 58: IVD Market, China, Revenue ($m), 2009-2016 86
Figure 59: IVD Market, India, Revenue ($m), 2002-2009 87
Figure 60: IVD Market, India, Revenue ($m), 2002-2009 88
Figure 61: IVD Market, Australia, Revenue ($m), 2002-2009 90
Figure 62: IVD Market, Australia, Revenue ($m), 2009-2016 91
Figure 63: IVD Market, Taiwan, Revenue ($m), 2002-2009 92
Figure 64: IVD Market, Taiwan, Revenue ($m), 2009-2016 93
Figure 65: IVD Market, Republic of Korea, Revenue ($m), 2002-2009 94
Figure 66: IVD Market, Republic of Korea, Revenue ($m), 2009-2016 95
Figure 67: IVD Market, Brazil, Revenue ($m), 2002-2009 97
Figure 68: IVD Market, Brazil, Revenue ($m), 2009-2016 98
Figure 69: IVD Market, Argentina, Revenue ($m), 2002-2009 99
Figure 70: IVD Market, Argentina, Revenue ($m), 2009-2016 100
Figure 71: IVD Market, Mexico, Revenue ($m), 2002-2009 101
Figure 72: IVD Market, Mexico, Revenue ($m), 2009-2016 102
Figure 73: IVD Market, Israel, Revenue ($m), 2002-2009 104
Figure 74: IVD Market, Israel, Revenue ($m), 2009-2016 105
Figure 75: IVD Market, South Africa, Revenue ($m), 2002-2009 106
Figure 76: IVD Market, South Africa, Revenue ($m), 2009-2016 107
Figure 77: IVD Market, Global, Pipeline Products Analysis by Category, 2009 124
Figure 78: Immuno Chemistry Market, Global, Pipeline Products Analysis, 2009 125
Figure 79: Infectious Immunology Market, Global, 2009 126
Figure 80: Deals By Type, Global IVD Market, 2006-2009 131
Figure 81: Deals By Value and Volume, Global IVD Market, Value ($m), 2006-2009 132
Figure 82: GBI Research Methodology 145
Companies Mentioned
F. Hoffmann-La Roche Ltd
Siemens Medical Solutions USA, Inc.
Abbott Laboratories
Beckman Coulter, Inc
bioMerieux Sa
Ortho-Clinical Diagnostics
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Inverness Medical Innovations, Inc
To order this report:
In Vitro Diagnostic Industry: The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg |
|
Reportlinker |
|
Email: [email protected] |
|
US: (805)652-2626 |
|
Intl: +1 805-652-2626 |
|
SOURCE Reportlinker
Share this article